Hovinga K.E. et al., EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma, , J Neurooncol., Apr 01, 2019 ➔

Ham I.-H. et. al., Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer, , Mol Cancer. , Mar 30, 2019 ➔

Puca L. et. al., Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer, , Sci Transl Med., Mar 30, 2019 ➔

Koosha S. et. al., Investigation into the Molecular Mechanisms underlying the Anti-proliferative and Anti-tumorigenesis activities of Diosmetin against HCT-116 Human Colorectal Cancer, , Sci Rep, Mar 26, 2019 ➔

Karlsson A. et. al., A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer, , Sci Rep, Mar 26, 2019 ➔

Formisano L. et. al., Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer, , Nat Commun. , Mar 26, 2019 ➔

Liu J. et. al., Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance, , PLoS One., Mar 26, 2019 ➔

Kasikara C. et. al., Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer, , Cancer Res, Mar 19, 2019 ➔

Weng Y.S. et. al., MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer, , Mol Cancer. , Mar 18, 2019 ➔

Wobser M. et. al., Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells, , J Hematol Oncol., Mar 18, 2019 ➔

Zhang L et al., Multiplatform Biomarker Identification using a Data-driven Approach Enables Single-sample Classification, , bioRxiv, Mar 18, 2019 ➔

Gobin M. et. al. A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications, , Cancer Res, Mar 15, 2019 ➔

Lavrov A.V. et. al., Exome, transcriptome and miRNA analysis don’t reveal any molecular markers of TKI efficacy in primary CML patients, , BMC Med Genomics., Mar 13, 2019 ➔

Oh S.H. et. al., The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia., , FASEB J., Mar 12, 2019 ➔

Rahman R.M.A. et al., Expression of Cathepsins B, D, and G in WHO Grade I Meningioma, , Front Surg, Mar 12, 2019 ➔